$1.24
-0.110 (-8.15%)
At Close: Jul 13, 2026
PainReform Announces $6.0 Million Private Placement
09:00am, Monday, 08'th Mar 2021
HERZLIYA, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulat
PainReform to Present at the H.C. Wainwright BioConnect 2021 Conference
08:30am, Thursday, 07'th Jan 2021
HERZLIYA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulati
Sign In
Buy PRFX